Published in Cell Mol Life Sci on February 18, 2010
Quinolones: from antibiotics to autoinducers. FEMS Microbiol Rev (2011) 1.75
Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target. Curr Drug Targets (2012) 1.07
Roles of eukaryotic topoisomerases in transcription, replication and genomic stability. Nat Rev Mol Cell Biol (2016) 1.05
Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents. PLoS One (2013) 0.96
Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons. Phytochem Rev (2014) 0.91
The SMC complex MukBEF recruits topoisomerase IV to the origin of replication region in live Escherichia coli. MBio (2014) 0.87
Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV. Nucleic Acids Res (2011) 0.86
MatP regulates the coordinated action of topoisomerase IV and MukBEF in chromosome segregation. Nat Commun (2016) 0.84
Structure of the N-terminal Gyrase B fragment in complex with ADP⋅Pi reveals rigid-body motion induced by ATP hydrolysis. PLoS One (2014) 0.82
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases. Bioorg Med Chem Lett (2011) 0.81
A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone. Curr Med Chem (2016) 0.75
A prodrug approach to the use of coumarins as potential therapeutics for superficial mycoses. PLoS One (2013) 0.75
DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. J Antimicrob Chemother (2017) 0.75
Recognition of DNA Supercoil Geometry by Mycobacterium tuberculosis Gyrase. Biochemistry (2017) 0.75
Effects of magnesium and related divalent metal ions in topoisomerase structure and function. Nucleic Acids Res (2009) 1.32
Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site. J Biol Chem (2005) 1.19
Aminoacyl-anthraquinone conjugates as telomerase inhibitors: synthesis, biophysical and biological evaluation. J Med Chem (2008) 1.10
Quinone methides tethered to naphthalene diimides as selective G-quadruplex alkylating agents. J Am Chem Soc (2009) 1.04
Hot-spot consensus of fluoroquinolone-mediated DNA cleavage by Gram-negative and Gram-positive type II DNA topoisomerases. Nucleic Acids Res (2007) 1.02
The evolving world of protein-G-quadruplex recognition: a medicinal chemist's perspective. Biochimie (2011) 0.99
The quinolone family: from antibacterial to anticancer agents. Curr Med Chem Anticancer Agents (2003) 0.97
A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter. J Med Chem (2013) 0.96
Photogeneration and reactivity of naphthoquinone methides as purine selective DNA alkylating agents. J Am Chem Soc (2010) 0.96
New anti-human immunodeficiency virus type 1 6-aminoquinolones: mechanism of action. Antimicrob Agents Chemother (2003) 0.94
Binol quinone methides as bisalkylating and DNA cross-linking agents. J Am Chem Soc (2004) 0.92
Toward efficient Zn(II)-based artificial nucleases. J Am Chem Soc (2004) 0.91
Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative. Antimicrob Agents Chemother (2004) 0.89
Structure modifications of 6-aminoquinolones with potent anti-HIV activity. J Med Chem (2004) 0.88
Formation of a unique cluster of G-quadruplex structures in the HIV-1 Nef coding region: implications for antiviral activity. PLoS One (2013) 0.87
Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin. Int J Cancer (2003) 0.86
Clerocidin alkylates DNA through its epoxide function: evidence for a fine tuned mechanism of action. Nucleic Acids Res (2003) 0.86
Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage. Autophagy (2012) 0.86
Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives. Bioorg Med Chem (2007) 0.86
Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents. J Med Chem (2003) 0.85
DNA gyrase requires DNA for effective two-site coordination of divalent metal ions: further insight into the mechanism of enzyme action. Biochemistry (2008) 0.85
Heterocyclic dications as a new class of telomeric G-quadruplex targeting agents. Curr Pharm Des (2012) 0.85
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein. Antimicrob Agents Chemother (2010) 0.85
Antiviral properties of quinolone-based drugs. Curr Drug Targets Infect Disord (2004) 0.84
Clerocidin selectively modifies the gyrase-DNA gate to induce irreversible and reversible DNA damage. Nucleic Acids Res (2008) 0.84
BINOL-amino acid conjugates as triggerable carriers of DNA-targeted potent photocytotoxic agents. J Med Chem (2007) 0.84
Synthesis and biological evaluation of 2-phenylquinolones targeted at Tat/TAR recognition. Bioorg Med Chem Lett (2008) 0.84
Naphthalene diimide scaffolds with dual reversible and covalent interaction properties towards G-quadruplex. Biochimie (2011) 0.83
Quinone methide generation via photoinduced electron transfer. J Org Chem (2011) 0.83
Concerted bis-alkylating reactivity of clerocidin towards unpaired cytosine residues in DNA. Nucleic Acids Res (2004) 0.82
Differential targeting of unpaired bases within duplex DNA by the natural compound clerocidin: a valuable tool to dissect DNA secondary structure. PLoS One (2012) 0.82
Clerocidin interacts with the cleavage complex of Streptococcus pneumoniae topoisomerase IV to induce selective irreversible DNA damage. Nucleic Acids Res (2006) 0.82
Antiviral 6-amino-quinolones: molecular basis for potency and selectivity. Bioorg Med Chem Lett (2005) 0.81
Antitumor AZA-anthrapyrazoles: biophysical and biochemical studies on 8- and 9-aza regioisomers. Biochem Pharmacol (2004) 0.81
Clerocidin-mediated DNA footprinting discriminates among different G-quadruplex conformations and detects tetraplex folding in a duplex environment. Biochim Biophys Acta (2013) 0.81
Folding versus charge: understanding selective target recognition by the thrombin aptamers. Curr Pharm Des (2012) 0.80
Effects of common buffer systems on drug activity: the case of clerocidin. Chem Res Toxicol (2004) 0.80
Reactivity of clerocidin towards adenine: implications for base-modulated DNA damage. Org Biomol Chem (2009) 0.80
Tuning G-quadruplex vs double-stranded DNA recognition in regioisomeric lysyl-peptidyl-anthraquinone conjugates. Bioconjug Chem (2011) 0.79
Development of DNA topoisomerase-related therapeutics: a short perspective of new challenges. Curr Med Chem Anticancer Agents (2004) 0.79
Perylene side chains modulate G-quadruplex conformation in biologically relevant DNA sequences. Bioorg Med Chem (2008) 0.79
Efficient plasmid DNA cleavage by a mononuclear copper(II) complex. Inorg Chem (2005) 0.79
Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human Cathepsin G. Biochem Pharmacol (2005) 0.79
Metal ion and inter-domain interactions as functional networks in E. coli topoisomerase I. Gene (2013) 0.78
Studies of anti-HIV transcription inhibitor quinolones: identification of potent N1-vinyl derivatives. ChemMedChem (2010) 0.78
Tuning the activity of Zn(II) complexes in DNA cleavage: clues for design of new efficient metallo-hydrolases. Inorg Chem (2008) 0.77
Effect of G-quadruplex polymorphism on the recognition of telomeric DNA by a metal complex. PLoS One (2013) 0.77
Metal ion-mediated assembly of effective phenanthroline-based G-quadruplex ligands. Dalton Trans (2009) 0.77
Interaction model for anthracycline activity against DNA topoisomerase II. Biochemistry (2004) 0.77
Simocyclinone D8 turns on against Gram-negative bacteria in a clinical setting. Bioorg Med Chem Lett (2009) 0.77
Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition. Bioorg Med Chem (2006) 0.77
Ni2+ and Cu2+ complexes of a phenanthroline-based ligand bind to G-quadruplexes at non-overlapping sites. Chem Commun (Camb) (2013) 0.77
Effective DNA inhibitors of cathepsin g by in vitro selection. Int J Mol Sci (2008) 0.76
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer. Biochem Pharmacol (2010) 0.76
Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patterns. Semin Thromb Hemost (2003) 0.76
Topoisomerase I involvement in schedule-dependent interaction between 5-fluoro-uracil and irinotecan in the treatment of colorectal cancer. Cancer Chemother Pharmacol (2009) 0.76
2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction. ChemMedChem (2009) 0.76
Antitumor potential of aza-bioisosterism in anthracenedione-based drugs. Curr Top Med Chem (2004) 0.75
Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-β1 expression in mesangial cells: biochemical and structural considerations. Glycobiology (2011) 0.75
2,6-Di(omega-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones: novel, potent, cytotoxic, and DNA-binding agents. J Med Chem (2002) 0.75
Bipyridyl ligands as photoactivatable mono- and bis-alkylating agents capable of DNA cross-linking. Org Biomol Chem (2006) 0.75
Rational design, synthesis, and DNA binding properties of novel sequence-selective peptidyl congeners of ametantrone. ChemMedChem (2010) 0.75
Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparins. Semin Thromb Hemost (2002) 0.75
Dissecting reactivity of clerocidin toward common buffer systems by means of selected drug analogues. Chem Res Toxicol (2005) 0.75
Novel ametantrone-amsacrine related hybrids as topoisomerase IIβ poisons and cytotoxic agents. Arch Pharm (Weinheim) (2014) 0.75
Intralesional topotecan in advanced ovarian cancer: a clinical report, based on a preclinical study. Oncol Rep (2002) 0.75
Alternative approaches to the discovery and development of telomerase-targeted anticancer drugs. Mini Rev Med Chem (2003) 0.75